𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) Study

✍ Scribed by Kim Fox; Roberto Ferrari; Michal Tendera; Philippe Gabriel Steg; Ian Ford


Book ID
116190496
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
193 KB
Volume
152
Category
Article
ISSN
1097-6744

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A Randomized, Double-Blind, Placebo-Cont
A multicentre, randomized, double-blind